Results of Q fever research - Widespread in the media

22 March 2018

Several newspapers, including Algemeen Dagblad, Brabants Dagblad and De Gelderlander, opened on 15 March with articles about the research results concerning the long-term effects of Q fever. The NOS paid attention to this research on Radio 1 and in the national television news, just like Hart van Nederland and EenVandaag.

Researcher and epidemiologist Ellen van Jaarsveld of the department of Primary and Community Care, was also guest at the news bulletin of Omroep Brabant. The widespread media attention led, among other things, to the fact that the research was also discussed in the House of Representatives. Ellen investigated the long-term effects of 2600 Q fever patients with several colleagues from the academic workshop AMPHI (infectious diseases). Especially patients with chronic Q fever experience an increase in symptoms over the years, says Ellen. Fatigue increases and quality of life decreases. In patients with Q Fever Fatigue Syndrome (QVS), the study shows, that patients up to 8 years after acute Q fever infection continue to have many complaints and physical limitations. The results of the research were presented on 15 March in Eindhoven during the final conference of Q-support, the foundation for patients with Q Fever.

https://www.ad.nl/binnenland/onderzoek-naar-q-koorts-ondanks-behandeling-worden-klachten-alleen-maar-erger~a833e156/
https://eenvandaag.avrotros.nl/item/nieuw-onderzoek-klachten-van-q-koortspatienten-worden-erger/

Want to know more about these subjects? Click on the buttons below for more news.

RIHS Health Evidence Urological cancers

Related news items

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.

Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.

29 July 2020

These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.

Improved method for detecting lung cancer

24 July 2020

Radboudumc researchers are the only ones in the Netherlands using a new method to make better lung cancer diagnoses earlier stage. Erik van der Heijden and Roel Verhoeven shows that the use of flexible imaging equipment via the natural respiratory tract contributes to a more accurate diagnosis.

Optimizing workup in head and neck cancer (HNC)

23 July 2020

In the journal Cancer RIHS researcher Henrieke Schutte described the outcomes after the implementation of a fast-track multidisciplinary integrated HNC care program: time-to-treatment was significantly reduced and survival and patient satisfaction increased significantly without increasing costs.